Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Miller Mary received 49,830 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Miller Mary (Chief Legal Officer) received 49,830 Acrivon Therapeutics, Inc. shares as an award, leaving 82,767 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 49,830 shares
- Holding after
- 82,767 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 49,830 | 82,767 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Miller Mary
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Miller Mary · Nov 19, 2026
- Form 4 · Miller Mary · Oct 26, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Miller Mary · Aug 20, 2026
- Form 4 · Miller Mary · Jul 23, 2026
- Form 4 · Devroe Eric · Nov 19, 2026
- Form 4 · Blume-Jensen Peter · Nov 19, 2026
- Form 4 · Peterson Katharine · Nov 19, 2026
- Form 4 · Gamelin Erick · Nov 19, 2026
- Form 4 · Levin Michaela · Sep 2, 2026